Seafood authenticity research moves into new stage
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
Showing 101 - 120 of 238 results
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
A lesson in Science and Sustainability.
The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.
Darren Mason is a senior business leader with over 30 years of experience in the nuclear, radiation, petrochemical, freight and energy sectors. He joined ANSTO in 2023 in a key role managing consultancy for calibration, training, nuclear waste and radi
Improving aquaculture for food production in Papua New Guinea
Explore ANSTO's range of publications and reports available for the public.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.
Using geoarchaeology to reconstruct the history of an ancient Khmer city.
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.